These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
497 related articles for article (PubMed ID: 29445100)
21. Nomogram based on pre-treatment inflammatory biomarkers predicting survival in patients with head and neck soft tissue sarcoma. Chen L; Zeng H; Du Z; Zhao Y; Ma X Cancer Biomark; 2020; 29(1):151-161. PubMed ID: 32623392 [TBL] [Abstract][Full Text] [Related]
22. Prognostic performance of inflammation-based prognostic indices in patients with resectable colorectal liver metastases. Neal CP; Cairns V; Jones MJ; Masood MM; Nana GR; Mann CD; Garcea G; Dennison AR Med Oncol; 2015 May; 32(5):144. PubMed ID: 25807934 [TBL] [Abstract][Full Text] [Related]
23. Preoperative systemic immune-inflammation index predicts prognosis and guides clinical treatment in patients with non-small cell lung cancer. Yan X; Li G Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32175568 [TBL] [Abstract][Full Text] [Related]
24. Predictive Values of Postoperative and Dynamic Changes of Inflammation Indexes in Survival of Patients with Resected Colorectal Cancer. Zhou ZQ; Pang S; Yu XC; Xue Q; Jiang HY; Liang XJ; Liu L Curr Med Sci; 2018 Oct; 38(5):798-808. PubMed ID: 30341514 [TBL] [Abstract][Full Text] [Related]
25. Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer. Tong YS; Tan J; Zhou XL; Song YQ; Song YJ J Transl Med; 2017 Oct; 15(1):221. PubMed ID: 29089030 [TBL] [Abstract][Full Text] [Related]
26. Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation? Solmaz Medeni S; Acar C; Olgun A; Acar A; Seyhanlı A; Taskıran E; Sevindik OG; Alacacıoglu I; Piskin O; Ozcan MA; Demirkan F; Undar B; Ozsan GH Clin Transplant; 2018 Sep; 32(9):e13359. PubMed ID: 30053318 [TBL] [Abstract][Full Text] [Related]
27. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer? Deng M; Ma X; Liang X; Zhu C; Wang M Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461 [TBL] [Abstract][Full Text] [Related]
28. The Role of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Platelets in the Prognosis of Metastatic Renal Cell Carcinoma. Huszno J; Kolosza Z; Mrochem-Kwarciak J; Rutkowski T; Skladowski K Oncology; 2019; 97(1):7-17. PubMed ID: 31048577 [TBL] [Abstract][Full Text] [Related]
29. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of outcomes in inflammatory breast cancer. Al Jarroudi O; El Bairi K; Abda N; Zaimi A; Jaouani L; Chibani H; Afqir S Biomark Med; 2021 Oct; 15(14):1289-1298. PubMed ID: 34486882 [No Abstract] [Full Text] [Related]
30. The prognostic value of systemic inflammation in patients undergoing surgery for colon cancer: comparison of composite ratios and cumulative scores. Dolan RD; McSorley ST; Park JH; Watt DG; Roxburgh CS; Horgan PG; McMillan DC Br J Cancer; 2018 Jul; 119(1):40-51. PubMed ID: 29789606 [TBL] [Abstract][Full Text] [Related]
31. Comparison of Hematologic and Other Prognostic Markers in Metastatic Colorectal Cancer. Mercier J; Voutsadakis IA J Gastrointest Cancer; 2019 Sep; 50(3):493-506. PubMed ID: 29704170 [TBL] [Abstract][Full Text] [Related]
32. Systemic immune response in squamous cell carcinoma of the head and neck: a comparative concordance index analysis. Tham T; Wotman M; Chung C; Ahn S; Dupuis H; Gliagias V; Movsesova T; Kraus D; Costantino P Eur Arch Otorhinolaryngol; 2019 Oct; 276(10):2913-2922. PubMed ID: 31312922 [TBL] [Abstract][Full Text] [Related]
33. Preoperative lymphocyte-monocyte and platelet-lymphocyte ratios as predictors of overall survival in patients with bladder cancer undergoing radical cystectomy. Zhang GM; Zhu Y; Luo L; Wan FN; Zhu YP; Sun LJ; Ye DW Tumour Biol; 2015 Nov; 36(11):8537-43. PubMed ID: 26032095 [TBL] [Abstract][Full Text] [Related]
34. Hematologic Markers of Lung Metastasis in Stage IV Colorectal Cancer. Abu-Shawer M; Abu-Shawer O; Souleiman M; Akkawi M; Alshakhatreh O; Altamimi T; Al-Omari A; Al-Hussaini M J Gastrointest Cancer; 2019 Sep; 50(3):428-433. PubMed ID: 29589285 [TBL] [Abstract][Full Text] [Related]
35. Preoperative neutrophil-lymphocyte ratio before platelet-lymphocyte ratio predicts clinical outcome in patients with cervical cancer treated with initial radical surgery. Zhang Y; Wang L; Liu Y; Wang S; Shang P; Gao Y; Chen X Int J Gynecol Cancer; 2014 Sep; 24(7):1319-25. PubMed ID: 25033256 [TBL] [Abstract][Full Text] [Related]
36. Survival and prognostic analysis of preoperative inflammatory markers in patients undergoing surgical resection for laryngeal squamous cell carcinoma. Chen L; Zeng H; Yang J; Lu Y; Zhang D; Wang J; Kuang C; Zhu S; Wang M; Ma X BMC Cancer; 2018 Aug; 18(1):816. PubMed ID: 30103707 [TBL] [Abstract][Full Text] [Related]
37. Preoperative neutrophil-to-lymphocyte ratio and plateletto- lymphocyte ratio as new prognostic factors for patients with colorectal cancer. Mahsuni Sevinc M; Riza Gunduz U; Kinaci E; Armagan Aydin A; Bayrak S; Umar Gursu R; Gunduz S J BUON; 2016; 21(5):1153-1157. PubMed ID: 27837617 [TBL] [Abstract][Full Text] [Related]
38. The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis. Guo YH; Sun HF; Zhang YB; Liao ZJ; Zhao L; Cui J; Wu T; Lu JR; Nan KJ; Wang SH Oncotarget; 2017 Mar; 8(12):20011-20024. PubMed ID: 28212553 [TBL] [Abstract][Full Text] [Related]
39. The prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with stage III non-small cell lung cancer treated with concurrent chemoradiotherapy. Yılmaz U; Ozdemir O; Batum O; Ermin S Indian J Cancer; 2018; 55(3):276-281. PubMed ID: 30693894 [TBL] [Abstract][Full Text] [Related]
40. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients. Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]